Mechanisms of Thrombocytopenia Induced by Interferon Therapy for Chronic Hepatitis B

Overview

Journal J Gastroenterol

Specialty Gastroenterology

Date 1997 Apr 1

PMID 9085169

Citations 4

Authors

M Sata

Y Yano

Y Yoshiyama

T Ide

R Kumashiro

H Suzuki

K Tanikawa

Affiliations

Soon will be listed here.

Abstract

To clarify the mechanisms of thrombocytopenia observed in patients with chronic hepatitis B treated with interferon. We studied six patients with chronic active hepatitis B who received intramuscular injections of natural interferon-alpha (3 or 5 million IU/ day) for 4 weeks. Peripheral blood platelet counts, bone marrow findings, and platelet kinetics, determined using 111In-labeled platelets, were analyzed. Platelets decreased significantly 1 week after the beginning of treatment and remained decreased until the completion of treatment. The number of nucleated cells and megakaryocytes in bone marrow decreased in three of five patients studied during treatment. The kinetic study showed platelet survival time to be 8.1 +/- 1.3 days (range, 5.8-10.0). One day after platelet injection, platelets accumulated predominantly in the splenic area in all patients, whereas hepatic accumulation was predominant 7 days after injection in three of the six patients. Thrombocytopenia during interferon treatment arises from the inhibition of stem cell proliferation and differentiation in the bone marrow and from the capture of platelets by the liver.

Citing Articles

Clinical spectrum and currently available treatment of type I interferonopathy Aicardi-Goutières syndrome.

DellIsola G, Dini G, Culpepper K, Portwood K, Ferrara P, Di Cara G World J Pediatr. 2023; 19(7):635-643.

PMID: 36650407 PMC: 10258176. DOI: 10.1007/s12519-022-00679-2.

The pathophysiology of thrombocytopenia in chronic liver disease.

Mitchell O, Feldman D, Diakow M, Sigal S Hepat Med. 2016; 8:39-50.

PMID: 27186144 PMC: 4847598. DOI: 10.2147/HMER.S74612.

Accumulation of platelets in the liver may be an important contributory factor to thrombocytopenia and liver fibrosis in chronic hepatitis C.

Kondo R, Yano H, Nakashima O, Tanikawa K, Nomura Y, Kage M J Gastroenterol. 2012; 48(4):526-34.

PMID: 22911171 DOI: 10.1007/s00535-012-0656-2.

Autoimmune thrombocytopenia induced by PEG-IFN-alpha2b plus ribavirin in hepatitis C.

Sagir A, Wettstein M, Heintges T, Haussinger D Dig Dis Sci. 2002; 47(3):562-3.

PMID: 11911342 DOI: 10.1023/a:1017964002402.

References

Peters A, Saverymuttu S, Malik F, Ind P, LAVENDER J . Intrahepatic kinetics of indium-111-labelled platelets. Thromb Haemost. 1985; 54(3):595-8. View

Dewanjee M, Rao S, Didisheim P . Indium-111 tropolone, a new high-affinity platelet label: preparation and evaluation of labeling parameters. J Nucl Med. 1981; 22(11):981-7. View

Davis G, BALART L, Schiff E, Lindsay K, Bodenheimer Jr H, Perrillo R . Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial. N Engl J Med. 1989; 321(22):1501-6. DOI: 10.1056/NEJM198911303212203. View

Schmidt K, Rasmussen J, Bekker C, MADSEN P . Kinetics and in vivo distribution of 111-In-labelled autologous platelets in chronic hepatic disease: mechanisms of thrombocytopenia. Scand J Haematol. 1985; 34(1):39-46. DOI: 10.1111/j.1600-0609.1985.tb00742.x. View

. Recommended methods for radioisotope platelet survival studies: by the panel on Diagnostic Application of Radioisotopes in Hematology, International Committee for Standardization in Hematology. Blood. 1977; 50(6):1137-44. View

van t Hull E, Schellekens H, Lowenberg B, De Vries M . Influence of interferon preparations on the proliferative capacity of human and mouse bone marrow cells in vitro. Cancer Res. 1978; 38(4):911-4. View

Cornacoff J, Hebert L, Smead W, VanAman M, Birmingham D, Waxman F . Primate erythrocyte-immune complex-clearing mechanism. J Clin Invest. 1983; 71(2):236-47. PMC: 436862. DOI: 10.1172/jci110764. View

Heyns A, Lotter M, Badenhorst P, Kotze H, Killian F, Herbst C . Kinetics and in vivo redistribution of (111)Indium-labelled human platelets after intravenous protamine sulphate. Thromb Haemost. 1980; 44(2):65-8. View

Mazur E, Richtsmeier W, South K . Alpha-interferon: differential suppression of colony growth from human erythroid, myeloid, and megakaryocytic hematopoietic progenitor cells. J Interferon Res. 1986; 6(3):199-206. DOI: 10.1089/jir.1986.6.199. View

10.

Toghill P, Green S . Platelet dynamics in chronic liver disease using the 111Indium oxine label. Gut. 1983; 24(1):49-52. PMC: 1419926. DOI: 10.1136/gut.24.1.49. View

11.

Herbert J, Savi P, Laplace M, Lale A, Dol F, Dumas A . IL-4 and IL-13 exhibit comparable abilities to reduce pyrogen-induced expression of procoagulant activity in endothelial cells and monocytes. FEBS Lett. 1993; 328(3):268-70. DOI: 10.1016/0014-5793(93)80941-m. View

12.

Prieto J, Yuste J, Beloqui O, Civeira M, Riezu J, Aguirre B . Anticardiolipin antibodies in chronic hepatitis C: implication of hepatitis C virus as the cause of the antiphospholipid syndrome. Hepatology. 1996; 23(2):199-204. DOI: 10.1002/hep.510230201. View

13.

Abdi E, Brien W, Venner P . Auto-immune thrombocytopenia related to interferon therapy. Scand J Haematol. 1986; 36(5):515-9. DOI: 10.1111/j.1600-0609.1986.tb02290.x. View

14.

Ernstoff M, Kirkwood J . Changes in the bone marrow of cancer patients treated with recombinant interferon alpha-2. Am J Med. 1984; 76(4):593-6. DOI: 10.1016/0002-9343(84)90282-1. View

15.

Hansson M, Beran M, Andersson B, Kiessling R . Inhibition of in vitro granulopoiesis by autologous allogeneic human NK cells. J Immunol. 1982; 129(1):126-32. View

16.

Talpaz M, Spitzer G, Hittelman W, Kantarjian H, Gutterman J . Changes in granulocyte-monocyte colony-forming cells among leukocyte-interferon-treated chronic myelogenous leukemia patients. Exp Hematol. 1986; 14(7):668-71. View

17.

Louwes H, BEEKHUIS H, Goedemans W, Keijser S, Schuurman J . 111In-tropolonate labelled platelets; studies in normals and in patients with thrombocytopenia. Eur J Nucl Med. 1987; 13(1):47-51. DOI: 10.1007/BF00252646. View

18.

Thakur M, Welch M, Joist J, Coleman R . Indium-LLL labeled platelets: studies on preparation and evaluation of in vitro and in vivo functions. Thromb Res. 1976; 9(4):345-57. DOI: 10.1016/0049-3848(76)90135-3. View

19.

Greenberg H, Pollard R, Lutwick L, GREGORY P, ROBINSON W, Merigan T . Effect of human leukocyte interferon on hepatitis B virus infection in patients with chronic active hepatitis. N Engl J Med. 1976; 295(10):517-22. DOI: 10.1056/NEJM197609022951001. View

20.

Neumann H, Fauser A . Effect of interferon on pluripotent hemopoietic progenitors (CFU-GEMM) derived from human bone marrow. Exp Hematol. 1982; 10(7):587-90. View